{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:52:33Z","timestamp":1769010753937,"version":"3.49.0"},"reference-count":40,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Although neurotoxicity is a major adverse event associated with busulfan, little information is available regarding the association between drug interactions and neurological symptoms during busulfan\u2010based regimens. This study evaluated the association between prophylactic echinocandins and neurological complications in patients receiving busulfan\u2010containing conditioning regimens for stem cell transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively included consecutive patients who administered intravenous busulfan as a conditioning regimen at our facility between 2007 and 2022. Prophylactic echinocandin use was defined as the use of an echinocandin antifungal drug to prevent invasive fungal disease in SCT recipients. The primary outcome was the incidence of neurological complications within 7\u2009days of busulfan initiation and was compared between the echinocandin group (patients received prophylactic echinocandin) and nonechinocandin group (patients received prophylactic antifungal drugs other than echinocandin and those without antifungal prophylaxis).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 59 patients included in this study, the incidence of neurological complications in the echinocandin (<jats:italic>n<\/jats:italic>\u2009=\u200926) and nonechinocandin groups (<jats:italic>n<\/jats:italic>\u2009=\u200933) was 30.8% and 63.6%, respectively. We observed a negative association between prophylactic echinocandin use and the development of neurological complications after adjusting for the propensity score for receiving prophylactic echinocandins (adjusted odds ratio 0.294, 95% confidence interval 0.090 to 0.959). We observed a lower incidence of neurological complications in the echinocandin group than in the nonechinocandin group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our results suggested that the choice of antifungal prophylaxis is associated with busulfan neurotoxicity.<\/jats:p><\/jats:sec>","DOI":"10.1111\/petr.14728","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T05:50:58Z","timestamp":1712814658000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of prophylactic echinocandin on the development of neurological complications in patients receiving busulfan\u2010containing conditioning regimens for stem cell transplantation: A single\u2010center retrospective study"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7118-7914","authenticated-orcid":false,"given":"Shogo","family":"Horikawa","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-8498","authenticated-orcid":false,"given":"Kenji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Hyodo","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Kozaki","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiichiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Kobe Children's Hospital  Kobe Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2362"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704707"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-530006"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.12.489"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704446"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13696"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02906128"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00877-z"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703612"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703047"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054777"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2002.v8.pm12374452"},{"key":"e_1_2_10_14_1","first-page":"6203","article-title":"Dose\u2010dependent neurotoxicity of high\u2010dose busulfan in children: a clinical and pharmacological study","volume":"50","author":"Vassal G","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.12.1502"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.10.028"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3659-8"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02795-8"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q087"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018010-00003"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250500183181"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.130"},{"key":"e_1_2_10_23_1","first-page":"2083","article-title":"Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)","volume":"16","author":"Buggia I","year":"1996","journal-title":"Anticancer Res"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.259"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.175"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02529.x"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.08.037"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111961"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/11585270-000000000-00000"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/00273171.2011.568786"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj047"},{"key":"e_1_2_10_33_1","first-page":"113","article-title":"Cerebrospinal fluid and plasma concentrations of busulfan during high\u2010dose therapy","volume":"4","author":"Hassan M","year":"1989","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558081"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058131"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701076"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-004-0237-0"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216651128"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14026"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24126"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02637-7"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.14728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T13:12:36Z","timestamp":1725628356000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/petr.14728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1111\/petr.14728"],"URL":"https:\/\/doi.org\/10.1111\/petr.14728","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"2023-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14728"}}